FDA daily

FDA daily for Tuesday, May 28, 2024

In this issue: 10 approvals, 1 device recall, 15 device decisions and 70 label changes. 2 items touch categories MedGrid carries, and they come first.

For MedGrid's categories

Items in this issue that name a product category sold on MedGrid. Each links to its full FDA record; the chip opens that category's federal and state rules.

Drug and biologic approvals

FDA date:

On Tue, May 21 FDA approved 5 new applications (0 brand or biologic, 5 generic) and 5 supplements to existing ones.

  • ALBUTEROL SULFATE

    ARMSTRONG PHARMS · ALBUTEROL SULFATE

    ANDA212447Generic (ANDA)Prescription
  • SUCRALFATE

    STRIDES PHARMA · SUCRALFATE

    ANDA216474Generic (ANDA)Prescription
  • CYCLOSPORINE

    DEVA HOLDING AS · CYCLOSPORINE

    ANDA209811Generic (ANDA)Prescription
  • LANREOTIDE ACETATE

    INVAGEN PHARMS · LANREOTIDE ACETATE

    ANDA217193Generic (ANDA)Discontinued
  • THEOPHYLLINE

    ZYDUS LIFESCIENCES · THEOPHYLLINE

    ANDA218063Generic (ANDA)Prescription
Browse drug and biologic approvals in FDA data →

Device recalls

FDA date:

FDA posted 1 device recall from 1 firm on Tue, May 21.

Browse device recalls in FDA data →

Device clearances and approvals

FDA date:

FDA decided 3 510(k)s and 12 PMA decisions on Tue, May 14.

Browse device clearances and approvals in FDA data →

Label updates

FDA date:

70 drug labels took effect on Tue, May 14; 3 of the 25 read for this issue are for products in MedGrid's categories. Below: those, and labels carrying a boxed warning.

Browse label updates in FDA data →

FDA did not answer for Drug shortages, Food and supplement recalls, Drug recalls while this issue was written; those sections will fill in on a later visit.

How the FDA daily is written

Every issue is written from FDA's public data (openFDA) and nothing else: the counts, names, firms and reasons are FDA's own. openFDA posts each kind of record on its own delay, so each section covers one FDA date and says which. Shortages cover yesterday; approvals, drug and device recalls, and food and supplement recalls cover a week ago; device clearances and label changes cover two weeks ago. Every FDA date appears in exactly one issue. Complete response letters appear the day after FDA publishes a batch.

Subscribe with any feed reader, or point an email tool at the RSS feed to send each issue as a newsletter. Search any drug, device or company across every FDA dataset in the FDA data explorer.

Read FDA's day. Stock your practice.

Join free with your NPI: wholesale pricing from verified vendors, with the FDA and state rules for each category one click away.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.